VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0929419
Sex: F
Age: 34
State: MA

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Fever, chills, bodyaches & shortness of breath - approx. 24 hours after receiving vaccine. Referred to ER for treatment.

Other Meds: Unknown

Current Illness: None

ID: 0929420
Sex: U
Age:
State: ID

Vax Date:
Onset Date: 12/29/2002
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: GARDASIL 9 and verbalized that it was administered after the temp excursion had ocurred; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information was given regarding the patient's concurrent conditions, concomitant medications or medical history. On 29-DEC-2020, the patient was vaccinated with an improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) with lot # 1687292 and expiration date on 25-AUG-2022 for prophylaxis (dose and route of administration were not reported). The administered dose experienced temperature excursion on 22-DEC-2020 at 22.7 F for 35 minutes and a previous temperature excursion was reported for 07-DEC-2020 at 32.6 F for 30 minutes. This call was because of a data logger. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687292; expirationdate: 25-AUG-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2101USA001792: US-009507513-2101USA001777:

Other Meds: GARDASIL 9 SYRINGE (DEVICE)

Current Illness:

ID: 0929421
Sex: U
Age:
State: IL

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A nurse inadvertently gave a dose of VAQTA to a 2-month-old; no other AE reported; This spontaneous report was received from a physician referring to a 2-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported.} On 05-JAN-2021, a nurse inadvertently gave a dose of hepatitis a vaccine, inactivated (VAQTA), 0.5 milliliter (additional dosage regimen information was not reported) for prophylaxis. It was mentioned that the physician ordered an hepatitis B vaccine, however, it was not reported that the patient also received this vaccine.

Other Meds:

Current Illness:

ID: 0929422
Sex: F
Age:
State:

Vax Date: 08/10/2020
Onset Date: 08/10/2020
Rec V Date: 01/08/2021
Hospital: Y

Lab Data: Test Date: 20200811; Test Name: Alanine Amino Transferase; Result Unstructured Data: (Test Result:16,Unit:u/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Aspartate Amino Transferase; Result Unstructured Data: (Test Result:19,Unit:u/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Alkaline phosphatase; Result Unstructured Data: (Test Result:140,Unit:u/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Calcium; Test Result: 8.9 mg/dl; Test Date: 20200811; Test Name: Chloride; Result Unstructured Data: (Test Result:106,Unit:mmol/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Creatinine; Test Result: 1.25 mg/dl; Test Date: 20200811; Test Name: Serum glucose; Test Result: 178 mg/dl; Test Date: 20200811; Test Name: Potassium; Result Unstructured Data: (Test Result:3.7,Unit:mmol/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Sodium; Result Unstructured Data: (Test Result:136,Unit:mmol/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Blood urea nitrogen; Test Result: 28 mg/dl; Test Date: 20200811; Test Name: Carbone dioxide; Result Unstructured Data: (Test Result:22,Unit:mmol/L,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Head CT; Result Unstructured Data: (Test Result:unknown,Unit:unknown,Normal Low:,Normal High:) CT Head without IV contrast done; Test Date: 20200811; Test Name: ECG; Result Unstructured Data: (Test Result:Normal,Unit:unknown,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Haematocrit; Test Result: 36.7 %; Test Date: 20200811; Test Name: Haemoglobin; Result Unstructured Data: (Test Result:11.8,Unit:unknown,Normal Low:,Normal High:) 11.8 g/dL; Test Date: 20200811; Test Name: Platelet count; Result Unstructured Data: (Test Result:194,Unit:k/mcl,Normal Low:,Normal High:); Test Date: 20200811; Test Name: Protein total; Result Unstructured Data: (Test Result:7.4,Unit:unknown,Normal Low:,Normal High:) 7.4g/dL; Test Date: 20200811; Test Name: White blood cell count; Result Unstructured Data: (Test Result:10.32,Unit:k/mcl,Normal Low:,Normal High:); Comments: On 11th August 2020 EKG done and results were within normal limits and CT Head without IV contrast.

Allergies:

Symptoms: Head injury; scalp lacerations; felt dizzy and next remembers waking up on the floor in blood; felt dizzy; received 2nd dose of shingrix late; headache; body aches; MYALGIA; This case was reported by a physician and described the occurrence of head injury in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included transient ischemic attack. Previously administered products included Shingrix (1st dose received on 10th September 2019). Concurrent medical conditions included anxiety, back pain, osteoporosis, sciatica, raynaud's syndrome, tension headache, constipation, hypercholesterolemia, hypertension, presbyopia, macular degeneration and drug allergy (in 2017). On 10th August 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 10th August 2020, less than a day after receiving Shingrix, the patient experienced headache, general body pain, myalgia and drug dose administration interval too long. On 11th August 2020, the patient experienced head injury (serious criteria hospitalization), scalp laceration (serious criteria hospitalization), loss of consciousness (serious criteria GSK medically significant) and dizziness. The patient was treated with DTPa (Reduced antigen) (Tdap Vaccine). On 10th August 2020, the outcome of the myalgia was recovered/resolved. On 11th August 2020, the outcome of the headache was recovered/resolved. On 20th August 2020, the outcome of the head injury and scalp laceration were recovered/resolved. On an unknown date, the outcome of the loss of consciousness, general body pain, dizziness and drug dose administration interval too long were unknown. It was unknown if the reporter considered the head injury, scalp laceration, loss of consciousness, headache, general body pain, myalgia and dizziness to be related to Shingrix. Additional details were reported as follows: On 11th August 2020, the following lab test were performed: Alanine aminotransferase result was 16 u/L, Aspartate aminotransferase result was 19 u/L, Blood alkaline phosphatase result was 140 u/L, Blood calcium result was 8.9 mg/dL, Blood chloride result was 106 mmol/L, Blood creatinine result was 1.25 mg/dL, Blood glucose result was 178 mg/dL, Blood potassium result was 3.7 mmol/L, Blood sodium result was 136 mmol/L, Blood urea result was 28 mg/dL, Carbon dioxide result was 22 mmol/L, Computerized tomogram head result was (without IV contrast) not provided, Electrocardiogram result was within normal limits, Haematocrit result was 36.7 percent, Haemoglobin result was 11.8 g/dL, Platelet count result was 194 k/mcl, Protein total result was 7.4 g/dL and White blood cell count result was 10.32 k/mcl. On 10th August 2020, the patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule and reported a headache and body aches. On the (early) morning of 11th August 2020, the headache worsened and when patient got out of bed to get OTC medication, she felt dizzy and next remembers waking up on the floor in blood and on the same day the patient went to emergency room, after the head injury and lacerations on scalp and was under observation. On 11th August 2020, the patient was treated with Tdap Vaccine for head injury and 2 scalp lacerations. On 13th August 2020, the patient was discharged. For tolerance of study drug refer case US2020214008.; Sender's Comments: US-GLAXOSMITHKLINE-US2020214008:same reporter

Other Meds:

Current Illness: Anxiety; Back pain; Constipation; Drug allergy (in 2017); Hypercholesterolemia; Hypertension; Macular degeneration; Osteoporosis; Presbyopia; Raynaud's syndrome; Sciatica; Tension headache

ID: 0929423
Sex: F
Age: 74
State: MI

Vax Date: 10/01/2020
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: cramps; gas; diarrhea; headache; fever; chills; started to feel sick; This case was reported by a consumer via call center representative and described the occurrence of cramp in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included diverticulitis and renal stone. Concurrent medical conditions included constipation. Concomitant products included plantago ovata (Metamucil). In October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced cramp, gas, diarrhea, headache, fever, chills and sickness. On an unknown date, the outcome of the cramp, gas, diarrhea, headache, fever, chills and sickness were unknown. It was unknown if the reporter considered the cramp, gas, diarrhea, headache, fever, chills and sickness to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix vaccine in her right arm and within 2 days started to feel sick with chills, fever, headache, diarrhea, gas, cramps. The patient had a history of kidney stones and history of diverticulitis and she has to take Metamucil to help with her constipation. The reporter consented to follow up.

Other Meds: METAMUCIL

Current Illness: Constipation

ID: 0929424
Sex: M
Age: 95
State: FL

Vax Date: 11/19/2020
Onset Date: 11/20/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizzy; "Wobbly on his feet." / needs to use a walker or cane; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 95-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 19th November 2020, the patient received the 2nd dose of Shingrix. On 20th November 2020, 1 days after receiving Shingrix, the patient experienced dizziness and unsteady gait. On an unknown date, the outcome of the dizziness and unsteady gait were not recovered/not resolved. It was unknown if the reporter considered the dizziness and unsteady gait to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix and feeling dizzy and wobbly on his feet needs to use a walker or cane to steady himself. The events had not resolved at time of report. The reporter unable to remain on the phone and did not provide demographics or any other information for this AE.

Other Meds:

Current Illness:

ID: 0929425
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Redness at injection site; Swelling at injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were unknown. It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix. Additional details were provided as follows: The age group was captured as adult as per vaccine indication. The reporter did not consent to follow-up. There was no vaccination date, injection site, patient's identifiers, lot number nor expiration date provided.

Other Meds:

Current Illness:

ID: 0929427
Sex: M
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: tested positive for COVID-19; tested positive for COVID-19; Headache; feeling unwell; muscle pain; This is a spontaneous report from a contactable nurse reporting on himself. A 61-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 28Dec2020 at 08:15 AM (at the age of 61 years old) as a single dose in the left arm for COVID-19 vaccination. Relevant medical history and concomitant medication were not provided. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Jan2021, the patient experienced mild side effects consisting of headache with feeling unwell and muscle pain. The patient reported this happened on 01Jan2021, and 02Jan2021 and on 03Jan2021 and later, the patient did not experience any side effect. Since the vaccination, the patient was tested for COVID-19 on 02Jan2021 with a Nasal Swab Rapid Test and tested positive for COVID-19. The adverse events resulted in Emergency room/department or urgent care visit. The patient did not receive any treatment for these events. The outcome of the events headache with feeling unwell and muscle pain and tested positive for COVID-19 was recovering. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0929428
Sex: F
Age:
State: KY

Vax Date: 12/21/2020
Onset Date: 12/29/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201229; Test Name: Temperature; Result Unstructured Data: Test Result:fever that night did not hit 100 degrees; Test Date: 20201231; Test Name: COVID-19 Rapid Test; Test Result: Positive

Allergies:

Symptoms: felt the need to have a COVID test, which turned out positive; felt the need to have a COVID test, which turned out positive; felt the need to have a COVID test, which turned out positive; Chills; Fever; This is a spontaneous report from a contactable Other HCP. A 55-year-old female patient received frist dose of BNT162B2 (Batch/lot number: EK5730) via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient explained receiving the COVID-19 vaccine on the 21Dec2020 and experienced fever and some chills. She pursed explaining that she was fine afterwards but felt the need to have a COVID test, which turned out positive of the 31Dec2020. The patient stated that she only had chills and fever the evening of 29Dec2020 and had been fine every since. Her fever that night did not hit 100 degrees. She thought that it would be better if she did not go to work on that Wednesday since she had had a fever the night before. She called her doctor who told her to come into the office on 31Dec2020 to have a rapid COVID test done and it came back positive. She only had fever and chills that one night and has not had any other symptoms. She received no treatment and did not take anything for the fever. This all happened during the night. She felt fine when she got up the next morning. Because she had received the first dose of the COVID vaccine, she thinks that this helped her. She thinks if she had not had the vaccine, then the virus would have been a lot worse. She stated that her second dose of the vaccine is scheduled on the 11Jan2021, and asked if it is safe to get the second dose of the COVID-19 vaccine. The outcome of events chills and fever was recovered; of other events was unknown.; Sender's Comments: The association between lack of effect (suspected COVID-19, SARS CoV2 test positive) with BNT162b2 can not be completely excluded.

Other Meds:

Current Illness:

ID: 0929429
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: COVID; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: Caller tested positive for COVID after the first dose; Caller tested positive for COVID after the first dose; This is a spontaneous report from an other Health Care Professional (HCP). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number and expiration date unknown) via an unspecified route of administration on an unspecified date (at an unknown age) at an unspecified dose for COVID-19 vaccination. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient tested positive for COVID after the first dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. The clinical outcome was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0929430
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: tested positive; Test Result: Positive

Allergies:

Symptoms: got the 1st dose of the vaccine then tested positive after; got the 1st dose of the vaccine then tested positive after; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the 1st dose of the vaccine then tested positive after. She was asking if she can get the 2nd dose even if she is tested positive. She asked if it can cause to have a false positive result if she received the vaccine. Outcome of the event was unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0929431
Sex: F
Age:
State: OH

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: there is pain radiating down the right side of her back and in the right side of her head and temple; Bad pain on right side of head, neck, and back; mild - moderate headache; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 11:15 on the left arm at single dose for COVID-19 immunisation. Medical history included immune disorder with high inflammatory markers, gluten intolerance, she is ANA positive (last time she was tested it was 2800) and allergic to sulfites. The patient's concomitant medications were not reported. The patient stated "she received vaccine on 30Dec2020. For the first 24 hours had no side effects, then developed a mild headache after 24 hours and 24 hours after that it worsened and developed pain on the right side of her neck that is like the stem of her headache and there is pain radiating down the right side of her back and in the right side of her head and temple. States that since this developed, it has persisted, not gotten worse or better. Wants to clarify that this does not involve her arms just her neck, head and back. States no amount of pain medication is working to relieve the pain. Ibuprofen is normally her go to and it did not work, she then tried the ADVIL LIQUIGELS, she took 400mg, states it was not working, she then got Bayer Back and Body to try because it has Aspirin in it, took 1500mg, three total pills, helped for an hour and then pain came back. Also tried a daytime THERAFLU just trying to get rid of the body aches, Good Sense Daytime Cold and Flu". The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929432
Sex: F
Age:
State: VA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tingling in mouth, numb tongue and lips; numb tongue and lips; This is a spontaneous report from a contactable pharmacist. A 59-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL0142), intramuscular on 04Jan2021 14:30 at single dose at left arm for COVID-19 immunization. There was no medical history reported. Concomitant medication included pravastatin, levothyroxine, colecalciferol (VITAMIN D [COLECALCIFEROL]), calcium, glucose oxidase, lactoferrin, lactoperoxidase, lysozyme, sodium fluorophosphate (BIOTENE [GLUCOSE OXIDASE;LACTOFERRIN;LACTOPEROXIDASE;LYSOZYME;SODIUM FLUOROPHOSPHATE]). On 04Jan2021 14:45, within 15 min observation period, the patient experienced tingling in mouth, numb tongue and lips. No throat swelling. The patient was given 25mg diphenhydramine. Therapeutic measures were taken as a result of tingling in mouth, numb tongue and lips. The outcome of the event was recovered in Jan2021.

Other Meds: ; ; VITAMIN D [COLECALCIFEROL]; ; BIOTENE [GLUCOSE OXIDASE;LACTOFERRIN;LACTOPEROXIDASE;LYSOZYME;SODIUM FLUOROPHOSPHATE]

Current Illness:

ID: 0929433
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen; redness, slightly swollen, and a small rash around injection site; redness, slightly swollen, and a small rash around injection site; redness, slightly swollen, and a small rash around injection site; Tiredness; rash from the face mask; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as Age: 77, Unit: Unspecified) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included tested positive for covid on 01Jul2020. The patient's concomitant medications were not reported. The patient received Covid 19 vaccine on 02Jan2021. In Jan2021, she experienced still swollen, redness, slightly swollen, and a small rash around injection site. She felt tiredness. She also got a rash from the face mask. She is calling to inquire if these side effects are common and how to treat. The outcome of the events tiredness and rash from the face mask was unknown, while for the other events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929434
Sex: M
Age:
State: CA

Vax Date: 12/17/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lesions emerged on right flexar surface of forearm, then left extensor surfaces of thumb, digits 4-5.; assymetric maculopapular rash, starting C6 midline posterior cervical skin (2x3cm circular red raised plaque with vesicles in middle)/On 04Jan2021, noted similar maculopapular rash; Vesicles firm on day 1, intensly pruitic, then broke with clear serosanguinous drainage and healing; This is a spontaneous report from a contactable physician. A 36-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EH9899), via an unspecified route of administration on 17Dec2020 17:15 at, single dose at left arm for COVID-19 immunization. Medical history included seasonal allergy from an unknown date and unknown if ongoing. Concomitant medications included methylcellulose (CITRUCEL), and ibuprofen. On 30Dec2020, it was noted the patient had assymetric maculopapular rash, starting C6 midline posterior cervical skin (2x3cm circular red raised plaque with vesicles in middle). Vesicles firm on day 1, intensly pruitic, then broke with clear serosanguinous drainage and healing. On 31Dec2020, lesions emerged on right flexar surface of forearm, then left extensor surfaces of thumb, digits 4-5. On 04Jan2021, noted similar maculopapular rash on lateral waist lines. No history of atopy, allergies, asthma, or any diseases whatsoever. No history of rash. No new irritants, animals, household products, foods etc. The outcome of the events was recovering.

Other Meds: CITRUCEL;

Current Illness:

ID: 0929435
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/26/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: metallic taste in the mouth; tingling sensation; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date unknown, via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. Medical history included covid-19 from Jun2020 to an unknown date. The patient's concomitant medications were not reported. The patient received covid vaccine on 22Dec2020 and noticed around 4 days after (26Dec2020) had a metallic taste in the mouth and tingling sensation (persists until now), which according to her were similar to her symptoms when she had covid back in June. She was wondering if she can get the second dose of the vaccine which would probably be stronger. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929436
Sex: M
Age:
State: GA

Vax Date: 12/23/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: Rapid COVID test; Test Result: Negative ; Test Date: 20210101; Test Name: Regular COVID test; Test Result: Positive

Allergies:

Symptoms: his regular COVID test came back positive; his regular COVID test came back positive; This is a spontaneous report from a contactable nurse (reporting for himself) from a Pfizer-sponsored program. A 48-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported) via an unspecified route of administration, on 23Dec2020, single dose for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 23Dec2020, the patient received the COVID vaccine. On 28Dec2020, he had a negative rapid COVID test, and then on 01Jan2021 his regular COVID test came back positive. The patient would like to see if he should still get the second dose of the vaccine. Outcome of the events was unknown. Information on the Batch/Lot number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event SARS-CoV-2 test positive based on the known safety profile. However given the short duration of 9 days since the vaccine first dose, it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0929437
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date: 01/03/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210103; Test Name: covid; Test Result: Positive

Allergies:

Symptoms: tested positive for covid "yesterday"/asymptomatic; tested positive for covid "yesterday"/asymptomatic; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 21Dec2020 and was scheduled for the second on 11Jan2021. The patient tested positive for COVID yesterday, 03Jan2021 and wanted to know what to do about her second dose. The patient added that she was asymptomatic at this point and not taking any medications. Outcome of the events was unknown. The events was assessed as non-serious. Information on the lot/batch number has been requested.; Sender's Comments: The reported positive test with Covid-19 after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.

Other Meds:

Current Illness:

ID: 0929438
Sex: M
Age:
State: CA

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flu like symptoms; Low grade fever; Chills; body aches; sweating; fatigue; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 41-year-old male patient received BNT162B2 (lot ej1685) intramuscular on 29Dec2020 07:15 AM at a single dose on the left arm as COVID-19 vaccine. Medical history and concomitant medications were not reported. The patient had known allergies to sulfamethoxazole/trimethoprim (SEPTRA). The patient was vaccinated in a hospital (facility where the most recent COVID-19 vaccine was administered). He did not receive other vaccines within four weeks prior to the COVID vaccine. The patient experienced flu like symptoms, low grade fever, chills, body aches, sweating, fatigue, all on 30Dec2020 12:00. The events were non-serious which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the events. He was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The outcome of the events was recovered on 30Dec2020.

Other Meds:

Current Illness:

ID: 0929439
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe anaphylaxis; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 6 patients. This is the first of 6 reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration from an unspecified date at a single dose for vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced severe anaphylaxis, on an unspecified date. Outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003208 different patient/same drug/event;US-PFIZER INC-2021003209 different patient/same drug/event;US-PFIZER INC-2021003210 different patient/same drug/event;US-PFIZER INC-2021003211 different patient/same drug/event;US-PFIZER INC-2021003212 different patient/same drug/event

Other Meds:

Current Illness:

ID: 0929440
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for six patients. This is third of six reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported) via an unspecified route of administration on an unspecified date at a single dose as vaccination. Medical history and concomitant medications were not reported. The patient experienced severe anaphylaxis with vaccination on an unspecified date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003207 same drug/event and different patients

Other Meds:

Current Illness:

ID: 0929441
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe anaphylaxis; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 6 patients. This is 4th of six reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on an unspecified date at a single dose for vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced severe anaphylaxis with vaccination on an unspecified date. Outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003207 same drug/event and different patients

Other Meds:

Current Illness:

ID: 0929442
Sex: F
Age:
State: UT

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild to moderate injection site soreness 48 hours; This is a spontaneous report from a non-contactable other hcp. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date unknown, via an unspecified route of administration on 30Dec2020 19:30 at single dose for covid-19 immunisation. Medical history included rubber sensitivity from an unknown date and unknown if ongoing. Concomitant medication included amitriptyline (AMITRIPTYLINE), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) and colecalciferol (VITAMIN D [COLECALCIFEROL]). The patient experienced mild to moderate injection site soreness for 48 hours (non-serious) on 30Dec2020 20:00 with outcome of recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds: ; FLONASE [FLUTICASONE PROPIONATE]; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0929443
Sex: F
Age:
State: MD

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe neck pain; muscle pain that was almost like a horse in the muscles above her hips and in her back; muscle pain that was almost like a horse in the muscles above her hips and in her back; muscle cramping; pain in her arm; This is a spontaneous report from a contactable consumer. A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number 5K5730/expiration date unknown), dose number 1, via an unspecified route of administration on 18Dec2020 at a single dose on the left arm for COVID Prevention. The patient had no relevant medical history. Historical vaccine included flu vaccine for immunisation which caused arm pain. The patient had no concomitant medications. She had no other vaccines on the same day as the COVID vaccine. The patient received her first dose of the COVID vaccine on 18Dec2020, and at first, she just had pain in her arm. It started getting sore in the evening of 18Dec2020. She suspected that would happen, because she gets that with the flu shot too. A few days after receiving the vaccine, she had pretty severe neck pain, and at first she just thought that maybe she slept wrong, but she still had neck pain. She was sitting with hand warmer packs on her neck because the pain was at the point bad enough that she could barely turn her neck. She experienced muscle pain that was almost like a horse in the muscles above her hips and in her back. The pain in her hips and back is bad enough that it almost takes her down. The patient also experienced muscle cramping. She further stated that she had not done anything different; she did not got to the gym. She remembered that when she signed off to get the vaccine, there was something about not taking the vaccine if someone had ever had a side effect to a lipid. The outcome of the events was recovered on 20Dec2020 for pain in her arm, recovering for neck pain, not recovered for muscle pain that was almost like a horse in the muscles above her hips and in her back, unknown for muscle cramping.

Other Meds:

Current Illness:

ID: 0929444
Sex: F
Age:
State: AR

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lymphadenopathy; chills; tachycardia; weakness; feeling unwell; injection site was red, swollen, painful, and hot to the touch with a diameter of about 2inches; injection site was red, swollen, painful, and hot to the touch with a diameter of about 2inches; injection site was red, swollen, painful, and hot to the touch with a diameter of about 2inches; fever that reach 101.5F; injection site pain; myalgia in the entire left arm; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were unknown), via an unspecified route of administration on the left arm on 30Dec2020 18:00 at single dose for COVID-19 immunization. Medical history included polycystic ovarian syndrome (PCOS). Patient was diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient was not pregnant at the time for vaccination. Concomitant medication included metformin, ergocalciferol (VIT D), and tretinoin cream. Right after injection, the patient had injection site pain and myalgia in the entire left arm on 30Dec2020. The second day, 31Dec2020, about 19 hours after receiving the vaccine, patient started feeling unwell. The injection site was red, swollen, painful, and hot to the touch with a diameter of about 2inches on 30Dec2020. Patient developed a fever that reach 101.5F on 30Dec2020. She also experienced chills, tachycardia, and weakness about 24hours after injection on 31Dec2020. Patient experienced lymphadenopathy during the 3rd (01Jan2021) and 4th day (02Jan2021). Patient recovered with lasting effects (recovered with sequel). TYLENOL was received as treatment for the events except for lymphadenopathy. The reporter considered the events non-serious. Information on the Lot/Batch Number has been requested.

Other Meds: ; VIT D;

Current Illness:

ID: 0929445
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tongue swelled and tachycardic, shortness of breath; tongue swelled and tachycardic, shortness of breath; tongue swelled and tachycardic, shortness of breath; This is a spontaneous report from a contactable nurse reporting for herself. This 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EJ1685), via an unspecified route of administration at single dose on an unspecified date for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced tongue swelled and tachycardic, shortness of breath on an unspecified date with outcome of unknown. She stated that never dropped below 99, and she was treated with Benadryl 50mg and was told it was not an anaphylactic reaction. She should probably be okay to receive the second dose of the vaccine. Is that the recommendation or not? The patient wanted to know how to participate in a clinical trial after she gets 2nd dose of vaccine.

Other Meds:

Current Illness:

ID: 0929446
Sex: F
Age:
State: PA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tingling and numbness in the injection arm (left arm); tingling and numbness in the injection arm (left arm); This is a spontaneous report from a contactable nurse (patient). A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1086, expiration date: Mar2021), via an unspecified route of administration in the left arm on 04Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. On 04Jan2021, the patient received the COVID vaccine 30 minutes ago then the patient started having tingling and numbness in the injection arm (left arm). She wanted to know if this has been reported and how long will it last. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0929447
Sex: F
Age:
State: WV

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness at and around the injection site on the right upper arm; Coughing; tenderness in the axillary region of the right arm; slight swelling in the axillary region of the right arm; This is a spontaneous report from a contactable healthcare professional (patient herself). A 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date not reported), via an unspecified route of administration on the right arm on 31Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included biliary dyskinesia from an unknown date and unknown if ongoing, and cholecystectomy (gallbladder surgically removed Nov2019), irritable bowel syndrome subtype C (diagnosed Jul2020), and COVID-19 on an unspecified date prior vaccination. Concomitant medications included polyethylene glycol [macrogol] and amitriptyline. The patient experienced soreness at and around the injection site on the right upper arm on 01Jan2021 10:00; tenderness in the axillary region of the right arm on Jan2021; slight swelling in the axillary region of the right arm on Jan2021; and coughing on 01Jan2021 10:00. No therapeutic measure was taken as a result of the events. Clinical outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: POLYETHYLENE GLYCOL [MACROGOL];

Current Illness:

ID: 0929448
Sex: F
Age:
State: MN

Vax Date: 12/30/2020
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Prickling needles feeling soles feet bilaterally and some in palms hands; pain in hip joints; moderate leg aches bilaterally; Sore arm at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EJ1685), via an unspecified route of administration in the right arm, on 30Dec2020 at a single dose for COVID-19 immunization. The patient was 47 years old when she received the vaccine. Medical history included RSD (Reflex sympathetic dystrophy), had allergies to medications, food, or other product particularly NSAID and to contrast dye. The patient is not pregnant. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19 prior to vaccination. She had not been tested for Covid-19 since vaccination. The patient had sore arm at injection site for 36 hours after administration (02Jan2021) with outcome of recovered in Jan2021. In day #4 (03Jan2021), she had pain in hip joints and moderate leg aches bilaterally with outcome of unknown. In day #5 (04Jan2021), she had prickling needles feeling soles feet bilaterally and some in the palms of her hands with outcome of unknown. The events were reported as non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0929449
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe headache; muscle pain; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced severe headache and muscle pain. The reporter was asking if she should get her second dose of vaccine if she had experienced severe headache and muscle pain. Clinical outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0929450
Sex: F
Age:
State:

Vax Date: 12/19/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: COVID-19; Test Result: Positive ; Comments: diagnosed with COVID-19

Allergies:

Symptoms: diagnosed with COVID-19; diagnosed with COVID-19; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 19Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated, "I received the first dose of the COVID-19 vaccine last 19Dec2020 and unfortunately was exposed to COVID-19 in the evening. I was diagnosed with COVID-19 on 22Dec2020 or 23Dec2020. Should I have my second dose as scheduled tomorrow considering that I have the COVID-19?". The outcome of the event was unknown. Information on lot number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and COVID-19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 0929451
Sex: F
Age:
State: RI

Vax Date: 12/27/2020
Onset Date: 12/28/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Itchiness; Phlebitis; Looks like little flea bites on her skin. There isn't that many, its mostly on her upper torso and they are sporadically placed.; This is a spontaneous report from a contactable nurse (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0140; Expiration date was not reported), intramuscularly on the right deltoid, on 27Dec2020 (10:00) at a single dose for COVID-19 immunization at the hospital. Medical history included hypertension; hypothyroidism; was allergic to shellfish probably over the last 20 or 30 years; and was allergic to penicillin and sulfa "many, many years ago". Concomitant medications included HCTZ for hypertension; losartan potassium (COZAAR) for hypertension; levothyroxine sodium (SYNTHROID) for hypothyroidism; amlodipine for hypertension; omeprazole for hypertension; and ongoing lansoprazole (PREVACID). The patient previously took Fluzone Quadrivalent influenza vaccine on 17Oct2020 for vaccination, and had itchiness. On 28Dec2020, the patient had headache; itchiness; phlebitis; and had what looked like flea bites on her skin which were not that many, and was mostly on the upper torso and sporadically placed. The patient had received diphenhydramine (BENADRYL) as treatment for the events. The patient was told that since itchiness was not a part of the normal side effects, the itchiness was considered an adverse reaction and that she could not get her second shot which was scheduled for 16Jan2021. The outcome of the events was recovering for 'headache', 'pruritus' and 'phlebitis'; and was recovered on an unspecified date for 'looked like flea bites on her skin'.

Other Meds: HCTZ; COZAAR; SYNTHROID; ; ; PREVACID

Current Illness:

ID: 0929452
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201217; Test Name: covid test; Result Unstructured Data: Test Result:NEGATIVE

Allergies:

Symptoms: Nausea and headache still exist Day 6; Nausea and headache still exist Day 6; This is a spontaneous report from a non-contactable other healthcare professional. An adult female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1284; expiry date: unknown) intramuscular (arm left) on 30Dec2020 at 11:00, at a single dose, for COVID-19 immunization. Relevant medical history included unspecified allergies. Concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient showed a negative result on 17Dec2020. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered at patient's workplace (clinic). On 30Dec2020, at 15:00, the patient experienced nausea and headache which still exist until day 6. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has been tested post vaccination; however the results were unspecified. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0929453
Sex: F
Age:
State: NY

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen stiff arm at the site of the injection; Swollen stiff arm at the site of the injection; Nausea; Diarrhea; shivering; Sweating; Body ache; This is a spontaneous report from a contactable physician (patient). A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: PFL72TRA9899), intramuscular in left arm, on 31Dec2020 at 07:00, at a single dose, for COVID-19 immunization. The patient's medical history included COVID-19 (diagnosed prior to vaccination). There were no concomitant medications. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital. On 31Dec2020 at 8 PM (also reported as after exactly 12 hours; possibly discrepant), the patient experienced swollen stiff arm at the site of the injection, severe episode of nausea, diarrhea, shivering, sweating, and severe body ache. Treatment received for the adverse events included paracetamol (TYLENOL). The events were considered non-serious. Since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the events.

Other Meds:

Current Illness:

ID: 0929454
Sex: F
Age:
State: MA

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild pain at the injection site; tiredness; chills; headache; feeling unwell; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received bnt162b2 (BNT162B2; Pfizer-Biontech Covid-19 Vaccine also reported as vaccine A (Pfizer Ultracold); lot number: EH9899; expiration date: unknown), via an unspecified route of administration left arm on 22Dec2020 09:15 at a single dose for covid-19 vaccination. Medical history included anxiety and depression. The patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had other medications received within 2 weeks of vaccination. The patient most recent COVID-19 vaccine was administered a hospital. It was reported that 7 hours after vaccination (22Dec2020 04:15 PM [reported as 04:00PM]), the patient experienced mild pain at the injection site, tiredness, chills, headache, and feeling unwell. All resolved within 12 hours after sleep (23Dec2020 04:15). The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovered on 23Dec2020 04:15.

Other Meds:

Current Illness:

ID: 0929455
Sex: F
Age:
State: NY

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her arm started tingling/she was getting some tingling in her feet/getting all the sporadic tingling; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) via an unspecified route of administration, on 28Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown if patient is pregnant at the of vaccination, if patient was diagnosed with COVID prior vaccination, and if patient received other vaccines within four weeks prior to COVID vaccination. The patient received Pfizer COVID vaccine last Monday and a few hours afterwards her arm started tingling. A few days later she was getting some tingling in her feet and she's getting all the sporadic tingling that is not going away. She's not even sure if she should get the second shot of the vaccine. Outcome of the event was not recovered. It was unknown if patient has been tested for COVID-19 since vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929456
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling is radiating to her exterior chest and the area hurts at touch; swelling is radiating to her exterior chest and the area hurts at touch; headache; body ache; swelling of the lymph nodes; lymphoedema; This is a spontaneous report from a nurse Medical information team. A female patient of an unspecified age (Age: 85; units: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had headache and body ache next day after receiving the Pfizer COVID-19 vaccine. On 31Dec2020, the patient reported lymphoedema or swelling of the lymph nodes. The swelling was radiating to her exterior chest and the area hurts at touch. The patient received the first dose of Pfizer COVID-19 vaccine on the 18Dec2020. The nurse wanted to know if the patient can receive the second dose of Pizer Covid-19 vaccine despite her symptoms. The outcome of the events was unknown. Information on Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 0929457
Sex: F
Age:
State: NJ

Vax Date: 12/19/2020
Onset Date: 12/22/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Approximately 3 days later noticed facial swelling at the site of prior facial filler injection - around nasolabial folds and tear trough areas/minimal erythema and tenderness only on palpation; Approximately 3 days later noticed facial swelling at the site of prior facial filler injection - around nasolabial folds and tear trough areas/minimal erythema and tenderness only on palpation; Approximately 3 days later noticed facial swelling at the site of prior facial filler injection - around nasolabial folds and tear trough areas/minimal erythema and tenderness only on palpation; This is a spontaneous report from a contactable physician (patient herself). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) via an unspecified route of administration (arm left), on 19Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received facial filler Restylane, which was injected in Sep2019. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within two to four weeks prior to COVID vaccination. On 22Dec2020, approximately 3 days after vaccination, patient noticed facial swelling at the site of prior facial filler injection - around nasolabial folds and tear trough areas. There was minimal erythema and tenderness only on palpation. The events resolved approximately 3-4 days later (unspecified date in Dec2020). The events did not require intervention/treatment. Outcome of the events was recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929458
Sex: F
Age:
State: NY

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: Blood sugar; Result Unstructured Data: Test Result:Hard time keeping blood sugar up

Allergies:

Symptoms: hard time keeping blood sugar up; diarrhea; Hives; This is a spontaneous report from a contactable nurse (patient's sister). A 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) via an unspecified route of administration, in Dec2020, at a single dose, for COVID-19 immunization. Medical history included diabetic. The patient's concomitant medications were not reported. Registered nurse called regarding COVID-19 vaccine. Her sister who is also a nurse got the vaccine before she did sometime in Dec2020. About 18 hours after receiving the COVID 19 vaccine, her sister got diarrhea and was having a hard time keeping her blood sugar up. The patient did not receive treatment for events diarrhea or the blood sugar. Patient also experienced hives and used Benadryl as treatment. Nurse stated that she has not talked to her; unsure if all of these events resolved or not but thinks the diarrhea was better. Outcome of the event diarrhea was recovering, while for other events was unknown. Seriousness of the events was not provided. No further information is provided. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929459
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: right hand swelled and both feet and ankles; right hand swelled and both feet and ankles; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (BNT162B2), via an unspecified route of administration on 18Dec2020 at a single dose for COVID-19 immunisation. Medical history included COVID through the end of Oct and Nov020. The patient's concomitant medications were not reported. The patient stated that her hospital would like for her to receive the Pfizer vaccine and she was told that it would boost her antibodies. She received the COVID vaccine on Friday, 18Dec2020. Afterwards, on an unspecified day in Dec2020, her right hand swelled and both feet and ankles. She called the nurse and was instructed to take Benadryl. She took the Benadryl for two days and then called her family practice physician who prescribed her a prednisone pack which helped with the swelling. The patient would like to know if she should receive the second shot, how effective the first dose would be if she doesn't receive the second shot, and what the interval is for the second dose of the Covid vaccine. Outcome of the event was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929460
Sex: F
Age:
State: WA

Vax Date: 12/22/2020
Onset Date: 12/29/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left deltoid was sore; left armpit was sore; It was sore to have left arm on side and it was sore when she layed on her left side to sleep. Soreness was radiating down her left side and into her left chest; left armpit is noticeably more swollen than right armpit; swollen, hard, lymph node which is not fixed when I palpate it; This is a spontaneous report from a contactable other healthcare professional (HCP), who is also the patient. This 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular in the left arm on 22Dec2020 at 12:00 at the age of 30 years at single dose for COVID-19 immunisation. Vaccination facility type: hospital. The patient did not receive other vaccines in four weeks and she did not receive other medications in two weeks. Relevant medical history included allergy to sulfa based medication. Concomitant medications were none. On 29Dec2020 at 17:00, the patient experienced left deltoid was sore, left armpit was sore, soreness was radiating down her left side and into her left chest, left armpit was noticeably more swollen than right armpit and swollen, hard, lymph node which was not fixed when she palpated it. The patient reported that for 2 days after the vaccination her left deltoid was sore which went away. Then, approximately 7-8 days after the vaccination, she noticed her left armpit was sore. This has persisted and the patient could feel a swollen, hard, lymph node which was not fixed when she palpated it. Her left armpit was noticeably more swollen than her right armpit (which wass normal appearing). It was sore to have left arm on side and it was sore when she layed on her left side to sleep. Soreness was radiating down her left side and into her left chest. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, she had not been tested for COVID-19. The patient did not receive corrective treatments for the reported events. At the time of the report, she had not recovered from the events. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929461
Sex: M
Age:
State: DE

Vax Date: 12/15/2020
Onset Date: 12/25/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: blood cultures; Result Unstructured Data: Test Result:Unknown result; Test Name: lactic acid; Result Unstructured Data: Test Result:Unknown result; Test Name: CBC; Result Unstructured Data: Test Result:Unknown result; Test Name: basic metabolic panel; Result Unstructured Data: Test Result:Unknown result; Test Date: 20201225; Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: Received the first COVID vaccine and then tested positive for COVID; Received the first COVID vaccine and then tested positive for COVID; This is a spontaneous report from Pfizer sponsored program Pfizer First Connect. A contactable nurse (patient) reported that a 22-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 15Dec2020 at single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient received the first COVID vaccine on 15Dec2020 and then tested positive for COVID on the 25Dec2020. He was not sure on the time frame, but he wanted to call in for an adverse event, just in case (incomplete sentence) and then he was scheduled to get the second dose within the next week or so. He forgot what date it was but, he wants to see if it was safe for him to get the second dose. The patient stated that he has a lot of lab work like blood cultures, basic metabolic panel, lactic acid, CBC; results were unknown. The outcome of the event was unknown. Information on the lot number/batch number has been requested.; Reporter's Comments: :; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be completely excluded for reported "tested positive for COVID".

Other Meds:

Current Illness:

ID: 0929462
Sex: M
Age:
State: CA

Vax Date: 12/28/2020
Onset Date: 01/04/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Covid test Nasal Swab; Test Result: Positive ; Comments: Tested positive for covid a week later after his first shot

Allergies:

Symptoms: Tested positive for covid a week later after his first shot; Tested positive for covid a week later after his first shot; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration in the left arm on 28Dec2020 at 12:00 PM in a hospital at a single dose as a COVID vaccine. The patient's medical history and concomitant medications were not reported. The patient had no known allergies but had other medical history (unspecified). The patient did not receive any other vaccine within four weeks prior to the COVID vaccine, had other medications in two weeks (unspecified), and was not diagnosed with COVID-19 prior to the vaccination. The patient tested positive for COVID a week later after his first shot. The test used was via nasal swab on 04Jan2021. The patient did not receive any treatment for the events. Outcome of the events was reported as recovering. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect). Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0929463
Sex: M
Age:
State:

Vax Date: 12/28/2020
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: Unknown; Result Unstructured Data: Test Result:Positive; Test Date: 20210102; Test Name: Covid 19 test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: Patient received Positive Covid 19 test result on 02Jan2021; Patient received Positive Covid 19 test result on 02Jan2021; This is a spontaneous report from contactable consumers. An adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: IL0140), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received positive COVID 19 test result on 02Jan2021. The patient had unknown test with positive result on 31Dec2020. The case was identified as non-serious by reporter. Facility where the most recent COVID-19 vaccine was administered was in hospital. It was unknown that the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown that the treatment received for the adverse event. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The outcome of event was recovering.

Other Meds:

Current Illness:

ID: 0929464
Sex: M
Age:
State: AZ

Vax Date: 01/03/2021
Onset Date: 01/04/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: Temperature; Result Unstructured Data: Test Result:99.7 Fahrenheit

Allergies:

Symptoms: body aches; running a fever; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EH9899), via an unspecified route of administration on 03Jan2021 at 12:30 at a single dose as a Covid vaccine. Medical history included bariatric surgery three months ago. He used to have high blood pressure, but after the surgery his blood pressure went away. Concomitant medications included multivitamins and calcium to keep himself healthy. On 04Jan2021, the patient was running a fever which started at 10:30 AM and he was concerned about going to work with the fever. He also had body aches on an unspecified date, but that could be because he went hiking for three days in a row. He told his boss, but said it could be because he went hiking. The patient clarified that he works from home and at the clinic. He didn't know if he should go. He was asking if it's ok to go to work. He was taking his temperature with two different things. It was reported that his temperature was 99.7 degrees Fahrenheit. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0929465
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lost her sense of smell and taste; lost her sense of smell and taste; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on 04Jan2021 at a single dose as COVID vaccine. The patient's medical history and concomitant medications were not reported. The patient stated that after she got the vaccine today (04Jan2021), she lost her sense of smell and taste. She asked if she can still get the vaccine and if it was normal. Outcome of the events was unknown. The case was reported as non-serious. No follow-up attempts are possible, information about the lot/batch cannot be obtained.

Other Meds:

Current Illness:

ID: 0929466
Sex: M
Age:
State: IL

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Right shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 25-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EJ1685), via an unspecified route of administration in the left deltoid on 22Dec2020 at a single dose as preventative and to protect the people around him. The patient had no relevant medical history and no concomitant medications. The patient stated that ever since he got the vaccine, he has had shoulder pain (onset date was on 24Dec2020). He was unsure if it was joint or muscular. When he raises it to a certain level, there was intense pain. This was only his right shoulder, he got the vaccine on his left side. The pain had stayed the same. It goes away every so often and then it comes back, that was with him helping it. He had used heat, taking Advil, and sometimes icing it. It had stayed the same and it has not gone away and it has not improved. The patient thinks his dose was 3mL, if he can recall. He stated that he did have one question. He was about to resume classes at his college and they were requesting that he took a tetanus shot and get a TB skin test. He was trying to figure out if that was okay. He remembers reading something that he should not get another vaccine at this time. If that was true, the patient was inquiring what was the time span. Outcome of the event was not recovered/not resolved.

Other Meds:

Current Illness:

ID: 0929467
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Asthma; cough; This is a spontaneous report from a contactable consumer. A currently 73-year-old received the vaccine at 67 or 68 years old, pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein (PREVNAR 13, lot number: unknown), via an unspecified route of administration in 2013 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The reported stated that back in 2013, his brother took the vaccine and within a year and half after he took it he developed asthma, also stated that neither one of them smoke or drink alcohol, seems there possibly seems to be a connection between the DNA. The reported added that his brother is now he is on maximum steroid for the treatment of it, has a cough that is just terrible, pulmonary specialist cannot seem to figure it out. The outcome of events was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0929468
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Headache, right hand numbing and tingling, stiff neck; Headache, right hand numbing and tingling, stiff neck; Headache, right hand numbing and tingling, stiff neck; Headache, right hand numbing and tingling, stiff neck; This is a spontaneous report from a non-contactable other healthcare professional. A 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On an unspecified date, the patient experienced headache, right hand numbing and tingling, and stiff neck. The patient did not receive treatment for the events. Outcome of the events was unknown. The patient underwent post vaccination nasal swab with an unknown result. No follow up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0929469
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: developed active Covid within 24 hours of receiving vaccine; developed active Covid within 24 hours of receiving vaccine; This is a spontaneous report from a contactable physician received via a Pfizer sales Representative. A female patient (physician) of an unspecified age received first dose of BNT162B2 via an unspecified route of administration on an unspecified date at a single dose as vaccine. Medical history included exposed to COVID-19 a few days prior to receiving the COVID-19 vaccine (works within a hospital and had been exposed to COVID-19 active infected patients). Concomitant medications were not reported. A physician reported that a female physician developed active Covid within 24 hours of receiving vaccine (also reported as received the vaccine and within 24 hours developed active symptoms of Covid) on an unspecified date. Requested information on whether to receive the second vaccine at this point. Unsure of the need or complications that could potentially rise from receiving a second vaccine in the series. The events took place after use of product. The outcome of the events was unknown. Information about Lot/Batch number has been requested.; Sender's Comments: There is not a reasonable possibility that reported "active Covid" is related to BNT162B2 vaccine. Event occurred within 24 hours of receiving vaccination, when the vaccine is not expected to achieve the effect. The event is most likely intercurrent medical condition.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm